KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Other Non-Current Assets (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Other Non-Current Assets for 16 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 million, a N/A change, with the full-year FY2024 number at $373000.0, down 97.57% from a year prior.
  • Other Non-Current Assets was $2.4 million for Q3 2025 at Biolife Solutions, up from $378000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $15.4 million in Q4 2023 to a low of $31000.0 in Q4 2022.
  • A 5-year average of $1.3 million and a median of $325000.0 in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: surged 49477.42% in 2023, then plummeted 97.57% in 2024.
  • Biolife Solutions' Other Non-Current Assets stood at $325000.0 in 2021, then tumbled by 90.46% to $31000.0 in 2022, then soared by 49477.42% to $15.4 million in 2023, then tumbled by 97.57% to $373000.0 in 2024, then skyrocketed by 548.53% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Other Non-Current Assets are $2.4 million (Q3 2025), $378000.0 (Q2 2025), and $378000.0 (Q1 2025).